Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

315.61
Delayed Data
As of Jun 18
 +0.31 / +0.10%
Today’s Change
281.89
Today|||52-Week Range
543.55
-16.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line348.1M636.1M895.5M1.2B
 
 
 
 
 
Depreciation52.7M74.9M104.7M145.5M
 
 
 
 
 
Total Other Cash Flow388.8M511.6M605.0M570.9M
 
 
 
 
 
Funds From Operations722.9M1.1B1.2B2.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-20.2M-229.8M-228.2M926.5M
 
 
 
 
 
Net Cash Flow - Operating Activities743.2M1.3B1.5B1.3B
 
 
 
 
 
 
InvestingIncrease In Investments-564.2M-557.1M-809.4M-1.3B
 
 
 
 
 
Decrease In Investments476.4M327.4M274.5M544.6M
 
 
 
 
 
Capital Expenditures-333.0M-677.9M-511.9M-272.6M
 
 
 
 
 
Net Cash Flow Investing-420.8M-907.6M-1.0B-1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.00----
Long Term Borrowings--26.0M--57.0M
 
 
 
Long Term Debt Reduction-221.7M-166.5M-40.6M-19.9M
 
 
 
 
 
Net Proceeds Stock Sale126.0M206.4M126.7M240.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing448.6M405.3M0.000.00
 
 
 
Other Uses - Financing562.1M734.0M786.5M301.7M
 
 
 
 
 
Net Cash Flow - Financing-209.3M-262.8M-700.4M-24.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash113.1M160.4M-273.9M277.5M